Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study.

European Heart Journal. Cardiovascular Pharmacotherapy
Marco ProiettiMaria Carla Roncaglioni

Abstract

Data on the impact of liver disease (LD) in patients with atrial fibrillation (AF) and the role of oral anticoagulant (OAC) drugs for stroke prevention are limited. A retrospective observational population-based cohort study on the administrative health databases of Lombardy region Italy. All AF patients ≥40 years admitted to hospital from 2000 to 2018 were considered. Atrial fibrillation and LD diagnosis were established using ICD9-CM codes. Use of OAC was determined with Anatomical Therapeutic Chemical codes. Primary study outcomes were stroke, major bleeding, and all-cause death. Among 393 507 AF patients, 16 168 (4.1%) had concomitant LD. Liver disease AF patients were significantly less treated with OAC. Concomitant LD was associated with an increased risk in all the study outcomes [hazard ratio (HR): 1.18, 95% confidence interval (CI): 1.11-1.25 for stroke; HR: 1.57, 95% CI: 1.47-1.66 for major bleeding; HR: 1.41, 95% CI: 1.39-1.44 for all-cause death]. Use of OAC in patients with AF and LD resulted in a reduction in stroke (HR: 0.80, 95% CI: 0.70-0.92), major bleeding (HR: 0.86, 95% CI: 0.74-0.99), and all-cause death (HR: 0.77, 95% CI: 0.73-0.80), with similar results according to subgroups. A net clinical benefit (NCB)...Continue Reading

References

Jul 15, 2011·The New England Journal of Medicine·Armando Tripodi, Pier Mannuccio Mannucci
Dec 3, 2014·International Journal of Cardiology·Seung-Jun LeeBoyoung Joung
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
May 24, 2016·Journal of Hepatology·Giovanni TargherCorrado Barbui
Nov 2, 2016·The American Journal of Gastroenterology·Armando TripodiStephen H Caldwell
Dec 27, 2016·Diabetes & Metabolic Syndrome·Toufik Mahfood HaddadVenkata M Alla
May 12, 2018·Journal of the American College of Cardiology·Arman QamarRobert P Giugliano
Dec 31, 2018·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Ronpichai ChokesuwattanaskulWisit Cheungpasitporn
Mar 2, 2019·Journal of the American College of Cardiology·Eric P StahlLaurence S Sperling
Mar 19, 2019·Journal of Clinical Gastroenterology·Kexin ZhengXingshun Qi
Jun 28, 2019·Internal and Emergency Medicine·Irene MarzonaMaria Carla Roncaglioni
Jun 30, 2019·Journal of the American College of Cardiology·So-Ryoung LeeGregory Y H Lip
Jun 30, 2019·Journal of the American College of Cardiology·Elaine M Hylek, Frank A Anania
Nov 2, 2019·Mayo Clinic Proceedings·Marco ProiettiAlessandro Nobili

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.